Metraipolis › archive › dc_eb7cb7ab4f1e

Significant gap between Point participation and long‑term treatment adherence: An evaluation of ivermectin MDA in the Kwanware‑Ottou persistent onchocerciasis… — Europe PMC PMID:41758867

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41758867
DOI
10.1371/journal.pntd.0013171
License (as archived)
solo-consultazione
Archived
2026-10-18T10:39:30.723Z
SHA-256 of the archived text
a09f3d6c4e1d7d01b22dc05d2afed69f5160c8256edc483fde4475d4fc7fe966
Stable URL of this page
https://metraipolis.com/documento/dc_eb7cb7ab4f1e

How to cite

Significant gap between Point participation and long‑term treatment adherence: An evaluation of ivermectin MDA in the Kwanware‑Ottou persistent onchocerciasis… — Europe PMC PMID:41758867 — Europe PMC (en), https://europepmc.org/article/MED/41758867 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb7cb7ab4f1e (Metraipolis archive dc_eb7cb7ab4f1e, sha256 a09f3d6c4e1d7d01b22dc05d2afed69f5160c8256edc483fde4475d4fc7fe966)
BibTeX
@misc{dceb7cb7ab4f1e,
  title = {Significant gap between Point participation and long‑term treatment adherence: An evaluation of ivermectin MDA in the Kwanware‑Ottou persistent onchocerciasis… — Europe PMC PMID:41758867},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41758867},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb7cb7ab4f1e; sha256 a09f3d6c4e1d7d01b22dc05d2afed69f5160c8256edc483fde4475d4fc7fe966},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41758867. Agents can read the archived copy with the MCP tool read_document.